These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 37150326)
1. Lipid nanoparticle-mediated drug delivery to the brain. Khare P; Edgecomb SX; Hamadani CM; Tanner EEL; S Manickam D Adv Drug Deliv Rev; 2023 Jun; 197():114861. PubMed ID: 37150326 [TBL] [Abstract][Full Text] [Related]
2. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells. Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640 [TBL] [Abstract][Full Text] [Related]
3. Chemistry of Lipid Nanoparticles for RNA Delivery. Eygeris Y; Gupta M; Kim J; Sahay G Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635 [TBL] [Abstract][Full Text] [Related]
4. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388 [TBL] [Abstract][Full Text] [Related]
5. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Suzuki Y; Ishihara H Drug Metab Pharmacokinet; 2021 Dec; 41():100424. PubMed ID: 34757287 [TBL] [Abstract][Full Text] [Related]
6. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells. Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines. Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150 [TBL] [Abstract][Full Text] [Related]
8. Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood-Brain Barrier Transfection and Crossing. Han EL; Padilla MS; Palanki R; Kim D; Mrksich K; Li JJ; Tang S; Yoon IC; Mitchell MJ Nano Lett; 2024 Feb; 24(5):1477-1486. PubMed ID: 38259198 [TBL] [Abstract][Full Text] [Related]
9. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs. Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467 [TBL] [Abstract][Full Text] [Related]
10. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery. Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697 [TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Jeong M; Lee Y; Park J; Jung H; Lee H Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563 [TBL] [Abstract][Full Text] [Related]
12. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076 [TBL] [Abstract][Full Text] [Related]
14. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery. Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654 [TBL] [Abstract][Full Text] [Related]
15. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids. Sato Y Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281 [TBL] [Abstract][Full Text] [Related]
16. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing. Qiu M; Li Y; Bloomer H; Xu Q Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716 [TBL] [Abstract][Full Text] [Related]
20. An Efficacy and Mechanism Driven Study on the Impact of Hypoxia on Lipid Nanoparticle Mediated mRNA Delivery. Ma Y; Fenton OS J Am Chem Soc; 2023 May; 145(20):11375-11386. PubMed ID: 37184377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]